๐Ÿ‡บ๐Ÿ‡ธ FDA

Intelligence ยท Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors โ€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ€” searchable for business development and competitive intelligence.

514 results for โ€œVirโ€ Clear

  1. Virulizinยฎ

    Aptose Biosciences

    Pancreatic Cancer

    phase 3 small molecule completed

    1 trial

  2. Zovirax 50 mg/g crema, Lipovir 50 mg/g Gel, Placebo

    Lacuna Pharma Pty Ltd

    Recurrent herpes labialis (RHL)

    phase 3 small molecule active

    1 trial

  3. acyclovir

    Ultragenyx UK Limited

    Herpes Simplex

    phase 3 small molecule completed

    2 trials

  4. bamlanivimab 7000mg

    SAB Biotherapeutics

    Coronavirus

    phase 3 mab completed

    1 trial

  5. bivalent enterovirus vaccine (Vero cell), inactivated

    Sinovac Research and Development Co.,

    Hand, Foot, and Mouth Disease๏ผˆHFMD)

    phase 3 mab active

    1 trial

  6. daclatasvir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis C

    phase 3 small molecule completed

    1 trial

  7. ganciclovir

    Ultragenyx UK Limited

    Cytomegalovirus Infections

    phase 3 small molecule completed

    1 trial

  8. mRNA-1647, Sodium Chloride 0.9%, Solution for Injection

    Moderna Biotech Spain

    Cytomegalovirus Infection (CMV)

    phase 3 small molecule active

    1 trial

  9. maribavir

    Takeda

    Cytomegalovirus Infections

    phase 3 small molecule completed

    2 trials

  10. maribavir, Maribavir, LIVTENCITY 200 mg film-coated tablets., Maribavir

    Takeda

    Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT)

    phase 3 small molecule active

    1 trial

  11. poliovirus vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Poliomyelitis

    phase 3 mab completed

    1 trial

  12. sotrovimab

    Vir Biotechnology

    Covid19

    phase 3 mab terminated

    3 trials

  13. stavudine, efavirenz, lamivudine

    Bristol-Myers Squibb

    HIV Infections

    phase 3 small molecule completed

    1 trial

  14. -

    The George Institute

    Cytomegalovirus infection post allogeneic allogeneic HLA-identical familial PHT

    phase 2 small molecule active

    1 trial

  15. 1% tenofovir gel

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 2 small molecule completed

    1 trial

  16. 100U EV71 vaccine with adjuvant

    Sinovac Research and Development Co.,

    Infection, Viral, Enterovirus

    phase 2 mab completed

    1 trial

  17. 400 U EV71 vaccine with adjuvant

    Sinovac Research and Development Co.,

    Infection, Viral, Enterovirus

    phase 2 mab terminated

    1 trial

  18. 851B

    Takeda

    Papillomavirus Infections

    phase 2 small molecule terminated

    2 trials

  19. A phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety, tolerability, and efficacy of S-337395 in symptomatic nonhospitalized adults with respiratory syncytial virus who are at high risk of progression to severe disease

    Shionogi B.V.

    Respiratory Syncytial Virus

    phase 2 other active

    1 trial

  20. A prospective, multi-centre study (B-Sure) to evaluate long-term durability of treatment response in chronic hepatitis B participants with and without nucleos(t)ide therapy who have participated in a previous bepirovirsen treatment study.

    GlaxoSmithKline

    Chronic Hepatitis B

    phase 2 other active

    1 trial

  21. ADENOVIRUS/PSA VACCINE

    United Therapeutics Europe Ltd

    Hormone Refractory Prostate Cancer

    phase 2 mab completed

    1 trial

  22. AK0529

    Shanghai University of Traditional Chinese Medicine

    RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

    phase 2 small molecule completed

    1 trial

  23. ALG-000184, ALG-000184 Placebo, Tenofovir Disoproxil Placebo, Tenofovirdisoproxil Amarox 245 mg Filmtabletten

    Aligos Therapeutics

    Chronic Hepatitis B Virus Infection

    phase 2 small molecule active

    1 trial

  24. ALN-RSV01

    Alnylam Netherlands B.V.

    Respiratory Syncytial Virus Infections

    phase 2 small molecule completed

    3 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ€“3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources